Quarterly report pursuant to Section 13 or 15(d)

Common Stock, and Preferred Stock (Details)

v3.23.3
Common Stock, and Preferred Stock (Details) - USD ($)
Jun. 13, 2023
Apr. 19, 2023
Sep. 30, 2023
Dec. 31, 2022
Common Stock, and Preferred Stock [Line Items]        
Common stock, shares authorized (in Shares)     500,000,000 500,000,000
Common stock par value     $ 0.1000 $ 0.1000
Aggregate price (in Dollars) $ 5,000,000      
Number of shares consideration (in Shares)   3,125,000    
Price per share $ 1.6 $ 1.6    
Common stock shares (in Shares) 9,375,342      
Exercise price per share   $ 1.75    
Breakeven warrants expire duration   7 years    
Pre-funded warrants exercise price   $ 0.0001    
pre-funded warrants [Member]        
Common Stock, and Preferred Stock [Line Items]        
Price per share   $ 0.0001    
Common stock shares (in Shares)   4,375,273    
Breakeven warrants [Member]        
Common Stock, and Preferred Stock [Line Items]        
Common stock shares (in Shares)   1,875,069    
Common Stock [Member]        
Common Stock, and Preferred Stock [Line Items]        
Common stock, shares authorized (in Shares)     500,000,000  
Common stock par value     $ 0.0001  
Preferred Stock [Member]        
Common Stock, and Preferred Stock [Line Items]        
Preferred stock, shares authorized (in Shares)     10,000,000  
Preferred stock, par value     $ 0.0001  
HCA Healthcare, Inc. [Member]        
Common Stock, and Preferred Stock [Line Items]        
Aggregate price (in Dollars)   $ 12,000,000